Related Experiment Video
Updated: May 7, 2026

Evaluation of Colorectal Cancer Risk and Prevalence by Stool DNA Integrity Detection
Published on: June 8, 2020
Relationship between serum uric acid and risk of ulcerative colitis and Crohn's disease: a prospective cohort study
Yijing Tie1,2, Peng Xie3,4, Kuan Li3,4
1Department of Epidemiology, School of Public Health, Southern Medical University, Guangzhou, 510515, Guangdong, China.
Background:
Serum uric acid (SUA) levels have been reported to be associated with various diseases, with both high and low levels potentially influencing inflammatory processes. However, epidemiological studies investigating the relationship between SUA levels, and the risk of ulcerative colitis (UC) and Crohn's disease (CD) are still limited.
Methods:
This cohort study recruited 438155 participants from the UK Biobank, with follow-up 2006 to 2010. During a mean follow-up of 12.6 years, we diagnosed 1904 cases of UC and 913 cases of CD. To assess the relationship between SUA levels and the incidence of UC and CD we categorized SUA levels (mg/dL) into six gender-specific quartiles (Q1-Q6) and performed Cox regression analysis with restricted cubic splines. Subsequently, we used Cox proportional hazards regression to analyze the effects of SUA levels on the risk of UC and CD.
Results:
In the analysis of UC, low SUA level-Q1 (SUA < 4.0 mg/dL) was consistently linked to an elevated risk across both statistical models (Model 1: HR = 1.27, 95% CI 1.03-1.56, P = 0.025; Model 2: HR = 1.30, 95% CI 1.04-1.62, P = 0.020). For CD, high SUA level-Q6 (SUA ≥ 8.0 mg/dL) was significantly associated with an increased risk (HR = 1.50, 95% CI 1.11-2.03, P = 0.008). In subgroup analyses, low SUA levels were significantly associated with an increased risk of UC, particularly among males. Conversely, high SUA levels were significantly linked to an elevated risk of CD, especially in females. These associations were also observed in several specific subgroups, including participants aged 60 years or older, individuals with a body mass index (BMI) ≥ 25 kg/m2, alcohol drinkers, and never-smokers.
Conclusion:
This study is the first to propose that SUA levels may serve as differential risk factors for UC and CD. Specifically, low SUA levels were associated with an increased risk of UC, whereas high levels were linked to a higher risk of CD. Subgroup analyses further identified additional risk factors. These findings provide novel insights into the distinct roles of SUA in the pathogenesis of UC and CD.
More Related Videos
Related Concept Videos
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids
However, this neutralization reaction between...
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease II: Ulcerative Colitis

